Anal & Cervical Cancer
Anal & Cervical Cancer
Researchers Identify Origin of Cervical Cancer Caused by Human Papillomavirus
- Details
- Category: Human Papillomavirus (HPV)
- Published on Wednesday, 20 June 2012 00:00
- Written by Press Release
Researchers have identified a population of cells in the uterine cervix that appears to give rise to dysplasia and cancer caused by human papillomavirus (HPV), according to a report in the June 11, 2012, Proceedings of the National Academy of Sciences.
ASCO 2012: Treatment of Anal Cancer in People with HIV
- Details
- Category: Human Papillomavirus (HPV)
- Published on Tuesday, 05 June 2012 00:00
- Written by Liz Highleyman
HIV positive people may experience more aggressive anal cancer progression and require prompt diagnosis, researchers reported at the American Society of Clinical Oncology Annual Meeting (ASCO 2012) taking place this week in Chicago. A related study found that quadruple combination anal cancer therapy is safe and may be effective for both HIV positive and negative patients.
Electrocautery Prevents Progression to Anal Cancer in HIV Positive and Negative Gay Men
- Details
- Category: Cancer/Malignancies
- Published on Tuesday, 03 January 2012 16:33
- Written by Liz Highleyman
Electrocautery ablation to remove abnormal tissue significantly reduced the likelihood of progression to anal cancer for both HIV positive and HIV negative gay men with high-grade anal intraepithelial neoplasia, according to a study described in the November 30, 2011, advance online edition of the Journal of Acquired Immune Deficiency Syndromes.
CROI 2012: Electrocautery Superior to Imiquimod or 5-Fluorouracil for Treatment of Anal Neoplasia
- Details
- Category: Cancer/Malignancies
- Published on Thursday, 15 March 2012 00:00
- Written by Gregory Fowler
Electrocautery was shown to be more effective and tolerable than topical imiquimod or 5-fluorouracil as a treatment for anal intraepithelial neoplasia (AIN) in HIV positive men who have sex with men (MSM), researchers reported in a late-breaker presentation at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) last week in Seattle.
Two HPV Vaccine Doses May Protect as Well as Three
- Details
- Category: Human Papillomavirus (HPV)
- Published on Monday, 12 September 2011 00:00
- Written by Liz Highleyman
The bivalent Cervarix human papillomavirus (HPV) vaccine may protect against cervical cancer with 2 doses, which would reduce inconvenience and cost compared with the current standard 3-dose regimen, according to study findings described in the September 9, 2011, advance online edition of the Journal of the National Cancer Institute.
Web Design and Development by